U.S. flag

An official website of the United States government

GTR Home > Tests > Hypertrophic Cardiomyopathy Panel

Indication

This is a clinical test intended for Help: Diagnosis

Clinical summary

Help

Isolated complex I deficiency is a rare inborn error of metabolism due to mutations in nuclear or mitochondrial genes encoding subunits or assembly factors of the human mitochondrial complex I (NADH: ubiquinone oxidoreductase) and is characterized by a wide range of manifestations including marked and often fatal lactic acidosis, cardiomyopathy, leukoencephalopathy, pure myopathy and hepatopathy with tubulopathy. Among the numerous clinical phenotypes observed are Leigh syndrome, Leber hereditary optic neuropathy and MELAS syndrome (see these terms). [from ORDO]

Clinical features

Help

Imported from Human Phenotype Ontology (HPO)

  • Lactic acidosis
  • Apnea
  • Ptosis
  • Cerebral edema
  • Hypertrophic cardiomyopathy
  • Cerebellar ataxia
  • Coma
  • Cyanosis
  • Dyskinesia
  • Sensorineural hearing impairment
  • Hepatomegaly
  • Hypoglycemia
  • Lethargy
  • Leukodystrophy
  • Hypotonia
  • Spasticity
  • Nystagmus
  • Babinski sign
  • Respiratory insufficiency
  • Splenomegaly
  • Strabismus
  • Vomiting
  • Hepatic failure
  • Muscle weakness
  • Hyperreflexia
  • Concentric hypertrophic cardiomyopathy
  • Tongue fasciculations
  • Hyper-beta-alaninemia
  • Leukoencephalopathy
  • Upslanted palpebral fissure
  • Exercise intolerance
  • Growth delay
  • Blindness
  • Bilateral tonic-clonic seizure
  • Skeletal muscle atrophy
  • Optic disc pallor
  • Global developmental delay
  • Hyporeflexia
  • Cerebellar atrophy
  • Hypospadias
  • Respiratory failure
  • Increased CSF lactate
  • Reduced eye contact
  • Poor head control
  • Developmental regression
  • Severe lactic acidosis
  • Undetectable visual evoked potentials
  • Acute necrotizing encephalopathy
  • Progressive macrocephaly
  • Failure to thrive
  • Feeding difficulties in infancy
  • Decreased activity of mitochondrial complex I
  • Decreased activity of mitochondrial complex III
  • Ragged-red muscle fibers
  • Short chin
  • Optic neuropathy
  • Increased intramyocellular lipid droplets
  • Focal T2 hypointense basal ganglia lesion
  • 3-hydroxydicarboxylic aciduria
  • Focal T2 hyperintense basal ganglia lesion
  • Lacticaciduria
  • Microcephaly
  • Elevated lactate:pyruvate ratio
Show all

Inheritance pattern

Help

Autosomal recessive inheritance

Conditions tested

Target population

Help

Providing a genetic evaluation for patients with a personal or family history suggestive of a hereditary form of hypertrophic cardiomyopathy. Establishing a diagnosis of a hereditary form of hypertrophic cardiomyopathy.

Citations

  • 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). - PubMed ID: 25173338
  • Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. - PubMed ID: 25741868
  • 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. - PubMed ID: 33215938

Clinical validity

Help

Not provided

Clinical utility

Help

Establish or confirm diagnosis

Citations
  • 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). - PubMed ID: 25173338
  • 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. - PubMed ID: 33215938

Predictive risk information for patient and/or family members

Citations
  • 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). - PubMed ID: 25173338
  • 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. - PubMed ID: 33215938

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.